DrugPatentWatch’s Custom Market Surveillance provides you with a robust platform to monitor your business opportunities from every angle. You’re monitoring your business, but you’re too busy to sift through data.…
Posts published in “Customer Success Stories”
How Much Time Are You Wasting on Manual, Repetitive Tasks? Stop wasting time on repetitive reports: Contact us Are your staff burdened with manual, repetitive tasks, like data collection, and…
When drug patents expire, billions of dollars in revenues can disappear overnight as competitors enter the market. Accordingly, many investors focus on drug patents when evaluating drug companies. But, there…
In response to customer requests, we’ve built some new tools for formulary management. You can preview these tools at: Recent Generic Drug Launches Upcoming 180-Day Patent Challenge Exclusivity Expirations Anticipate…
Let DrugPatentWatch build custom dashboards and reports to take the load off of your team. We can ensure the production of accurate, objective, and timely intelligence to help you quickly…
One of our clients, the Belarus Republican Scientific and Technical Library recently posted an article on how they support innovation. They open with the statement that “The novelty, effectiveness and…
DrugPatentWatch serves companies across the drug development-delivery sector. A common request among drug manufacturers, payers, and suppliers alike is anticipation of which branded drugs will face generic competition, and when…
Changes in drug markets can create growth opportunities for API manufacturers and CDMOs alike. Whether change comes from generic entry, from new formulations of drugs, or from competition from novel…
DrugPatentWatch has deep resources to support patent prosecution and patent litigation, but it is also used by law firms for business development. Find weak claims One of the first tweaks…
DrugPatentWatch can help identify generic entrants at the earliest stages Many clients come to DrugPatentWatch seeking to identify generic entrants well before they launch. CDMOs, equipment manufacturers, regulatory consultants, and…
